Next Article in Journal
Coumarin Ameliorates Impaired Bone Turnover by Inhibiting the Formation of Advanced Glycation End Products in Diabetic Osteoblasts and Osteoclasts
Next Article in Special Issue
ADAMTS1 Supports Endothelial Plasticity of Glioblastoma Cells with Relevance for Glioma Progression
Previous Article in Journal
Glutamate-Gated NMDA Receptors: Insights into the Function and Signaling in the Kidney
Previous Article in Special Issue
ADAMTS-15 Has a Tumor Suppressor Role in Prostate Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 10
Issue 7
10.3390/biom10071053
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Erratum to Biomolecules 2020, 10(3), 416.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

Erratum: Treatment of Dystrophic mdx Mice with an ADAMTS-5 Specific Monoclonal Antibody Increases the Ex Vivo Strength of Isolated Fast Twitch Hindlimb Muscles. Biomolecules 2020, 10, 416

by
Alex B. Addinsall
1,2,†,
Leonard G. Forgan
1,†,
Natasha L. McRae
1,
Rhys W. Kelly
1,
Penny L. McDonald
1,
Bryony McNeill
1,
Daniel R. McCulloch
1 and
Nicole Stupka
1,3,4,*
1
Centre for Molecular and Medical Research, School of Medicine, Deakin University, Waurn Ponds, VIC 3216, Australia
2
Department of Physiology and Pharmacology, Karolinska Insitutet, 171 77 Stockholm, Sweden
3
Department of Medicine—Western Health, The University of Melbourne, St. Albans, VIC 3021, Australia
4
Australian Institute for Musculoskeletal Science (AIMSS), 176 Furlong Road, St. Albans, VIC 3021, Australia
*
Author to whom correspondence should be addressed.
†
Authors contributed equally.
Biomolecules 2020, 10(7), 1053; https://doi.org/10.3390/biom10071053
Submission received: 9 July 2020 / Accepted: 10 July 2020 / Published: 15 July 2020
(This article belongs to the Special Issue New Insights on ADAMTS Proteases in Health)
Browse Figure
Versions Notes
The authors wish to make a change to this published paper [1]. In the original manuscript, there was a mistake in the labeling of the y-axis for Figure 5B,D. To assess muscle fatiguability, extensor digitorum longus (EDL) and soleus muscles were subjected to 4 min of intermittent (1 contraction every 5 s), submaximal stimulation at 60 Hz. The force output of every fifth contraction is statistically presented as a data point. The revision to Figure 5B,D now reflects the correct stimulation number.
The authors apologize for any inconvenience caused, and we wish to stress that this change does not affect the presented scientific results and statistical analyses. The manuscript with be updated and the original will remain online on the article webpage at https://www.mdpi.com/2218-273X/10/3/416.

Reference

  1. Addinsall, A.B.; Forgan, L.G.; McRae, N.L.; Kelly, R.W.; McDonald, P.L.; McNeil, B.; McCulloch, D.R.; Stupka, N. Treatment of Dystrophic mdx Mice with an ADAMTS-5 Specific Monoclonal Antibody Increases the Ex Vivo Strength of Isolated Fast Twitch Hindlimb Muscles. Biomolecules 2020, 10, 416. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Biomolecules 10 01053 g005 550
Figure 5. In mdx mice, ADAMTS-5 blockade improved the contractile function of fast EDL muscles. (A) Treatment with the ADAMTS-5 mAb increased the specific isometric force (sPo) output of EDL muscles. (B) During 4 min of intermittent 60 Hz stimulation, the relative fatigability of EDL muscles from mdx mice treated with the ADAMTS-5 mAb was reduced, and the relative force recovery was also improved. In soleus muscles, ADAMTS-5 blockade had no significant effect on (C) isometric strength or (D) fatigability and force recovery. * p < 0.05 and ** p < 0.001, main effect treatment, 2-way GLM-ANOVA. N = 17–19 mice.
Figure 5. In mdx mice, ADAMTS-5 blockade improved the contractile function of fast EDL muscles. (A) Treatment with the ADAMTS-5 mAb increased the specific isometric force (sPo) output of EDL muscles. (B) During 4 min of intermittent 60 Hz stimulation, the relative fatigability of EDL muscles from mdx mice treated with the ADAMTS-5 mAb was reduced, and the relative force recovery was also improved. In soleus muscles, ADAMTS-5 blockade had no significant effect on (C) isometric strength or (D) fatigability and force recovery. * p < 0.05 and ** p < 0.001, main effect treatment, 2-way GLM-ANOVA. N = 17–19 mice.
Biomolecules 10 01053 g005

Share and Cite

MDPI and ACS Style

Addinsall, A.B.; Forgan, L.G.; McRae, N.L.; Kelly, R.W.; McDonald, P.L.; McNeill, B.; McCulloch, D.R.; Stupka, N. Erratum: Treatment of Dystrophic mdx Mice with an ADAMTS-5 Specific Monoclonal Antibody Increases the Ex Vivo Strength of Isolated Fast Twitch Hindlimb Muscles. Biomolecules 2020, 10, 416. Biomolecules 2020, 10, 1053. https://doi.org/10.3390/biom10071053

AMA Style

Addinsall AB, Forgan LG, McRae NL, Kelly RW, McDonald PL, McNeill B, McCulloch DR, Stupka N. Erratum: Treatment of Dystrophic mdx Mice with an ADAMTS-5 Specific Monoclonal Antibody Increases the Ex Vivo Strength of Isolated Fast Twitch Hindlimb Muscles. Biomolecules 2020, 10, 416. Biomolecules. 2020; 10(7):1053. https://doi.org/10.3390/biom10071053

Chicago/Turabian Style

Addinsall, Alex B., Leonard G. Forgan, Natasha L. McRae, Rhys W. Kelly, Penny L. McDonald, Bryony McNeill, Daniel R. McCulloch, and Nicole Stupka. 2020. "Erratum: Treatment of Dystrophic mdx Mice with an ADAMTS-5 Specific Monoclonal Antibody Increases the Ex Vivo Strength of Isolated Fast Twitch Hindlimb Muscles. Biomolecules 2020, 10, 416" Biomolecules 10, no. 7: 1053. https://doi.org/10.3390/biom10071053

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop